amisulpride

Miscellaneous compounds - Amisulpride is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Reference standards of Amisulpride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Amisulpride - Impurity A
    [catalogue_number] => PA 01 46010
    [category_ids] => ,79,71,84,
    [chemical_name] => 
    [weight] => 128.22
    [form] => C7H16N2
    [cas] => 26116-12-1
    [pslug] => 26116-12-1-amisulpride-impurity-a-pa0146010
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 01 46010
PA 01 46010

Amisulpride - Impurity A


  • Catalogue No.:PA 01 46010

  • CAS :

    26116-12-1

  • Molecular Formula : C7H16N2

  • Molecular Weight : 128.22

stdClass Object
(
    [pname] => R-(+)-2-Aminomethyl-N-ethylpyrrolidine
    [catalogue_number] => PA 01 46650
    [category_ids] => ,79,69,84,
    [chemical_name] => 
    [weight] => 128.22
    [form] => C7H16N2
    [cas] => 22795-97-7
    [pslug] => 22795-97-7-r-2-aminomethyl-n-ethylpyrrolidine-pa0146650
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 01 46650
PA 01 46650

R-(+)-2-Aminomethyl-N-ethylpyrrolidine


  • Catalogue No.:PA 01 46650

  • CAS :

    22795-97-7

  • Molecular Formula : C7H16N2

  • Molecular Weight : 128.22

pharmaffiliates